Becker William C, Krebs Erin E, Edmond Sara N, Lin Lewei A, Sullivan Mark D, Weiss Roger D, Gordon Adam J
Pain Research, Informatics, Multimorbidities & Education Center of Innovation, VA Connecticut Healthcare System, West Haven, CT, USA.
Yale School of Medicine, New Haven, CT, USA.
J Gen Intern Med. 2020 Dec;35(Suppl 3):978-982. doi: 10.1007/s11606-020-06260-9. Epub 2020 Nov 3.
US military Veterans have been disproportionately impacted by the US opioid overdose crisis. In the fall of 2019, the Veterans Health Administration (VHA) convened a state-of-the-art (SOTA) conference to develop research priorities for advancing the science and clinical practice of opioid safety, including both use of opioid analgesics and managing opioid use disorder. We present the methods and consensus recommendations from the SOTA. A core group of researchers and VA clinical stakeholders defined three areas of focus for the SOTA: managing opioid use disorder, long-term opioid therapy for pain including consideration for opioid tapering, and treatment of co-occurring pain and substance use disorders. The SOTA participants divided into three workgroups and identified key questions and seminal studies related to those three areas of focus. The strongest recommendations included testing implementation strategies in the VHA for expanding access to medication treatment for opioid use disorder, testing collaborative tapering programs for patients prescribed long-term opioids, and larger trials of behavioral and exercise/movement interventions for pain among patients with substance use disorders.
美国退伍军人受美国阿片类药物过量危机的影响尤为严重。2019年秋季,退伍军人健康管理局(VHA)召开了一次前沿技术(SOTA)会议,以确定推进阿片类药物安全性科学研究和临床实践的研究重点,包括阿片类镇痛药的使用以及阿片类药物使用障碍的管理。我们介绍了此次前沿技术会议的方法和共识建议。一组核心研究人员和退伍军人事务部临床利益相关者为前沿技术会议确定了三个重点领域:管理阿片类药物使用障碍、疼痛的长期阿片类药物治疗(包括考虑阿片类药物减量)以及并发疼痛和物质使用障碍的治疗。前沿技术会议的参与者分成三个工作组,确定了与这三个重点领域相关的关键问题和开创性研究。最有力的建议包括在退伍军人事务部测试实施策略,以扩大阿片类药物使用障碍药物治疗的可及性;为长期服用阿片类药物的患者测试协作减量方案;以及针对物质使用障碍患者疼痛的行为和运动/活动干预进行更大规模的试验。